We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Stephen
Pilling
s.pilling@ucl.ac.uk
Ms
Katherine
Clarke
k.clarke@ucl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Disorders of adult personality and behaviourMood [affective] disordersSchizophrenia, schizotypal and delusional disordersUnspecified mental disorder
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This application concerns the final phase of a National Institute for Health Research (NIHR) programme grant investigating the development and evaluation of Open Dialogue (OD) for severe mental illness (ODDESSI, RP-PG-0615-20021). OD is a collaborative approach to the care and management of people who present in mental health crises and require continuing treatment and support. Its primary focus is on people’s social networks, in particular families, as well providing appropriate pharmaceutical, psychological or social interventions. It is in contrast to current models of care, in which families are rarely directly involved. International studies to date are promising and report reductions in hospital bed usage and improved recovery rates, but there is currently no high-quality evidence to support an NHS-wide adoption of this model. This approach offers the possibility of a potentially clinically and cost-effective alternative to current models of care. The programme grant consists of five Work Packages (WP) over a five-year period. We have already had HRA approval and undertaken the development phase (WP1) and the feasibility phase of the trial (WP2) (REC Reference: 18/LO/0868, IRAS Project ID: 233243). This application focuses on WPs 3, 4, and 5.
The current study aims to test the clinical and cost effectiveness of OD compared to treatment as usual. This will involve a multi-centre cluster randomised trial (WP 3) comparing OD with TAU in 5 mental health Trusts in England. In parallel with the trial, WP4 will examine a series of organisational and service related factors associated with the delivery and implementation of OD to inform the future implementation of OD, if OD is shown to be effective. As part of this the views and experience of people who have been received Open Dialogue will also be assessed (WP5
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Education or Self-Management;Psychological & Behavioural;Complex Intervention;Management of Care;Rehabilitation;Active Monitoring;
You can take part if:
You may not be able to take part if:
Service users are not eligible if they: •Have a diagnosis of dementia or a learning disability. •Have a primary diagnosis of substance misuse. •Have an acquired cognitive impairment. •Are under the care of forensic services. •Have no fixed abode. •Are participating in another research trial which may impact on their care or treatment in the ODDESSI programme. They will also be excluded if their participation in the study is judged to pose a risk of harm to themselves, study clinicians, or researchers.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Ms
Katherine
Clarke
k.clarke@ucl.ac.uk
Prof
Stephen
Pilling
s.pilling@ucl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by NORTH EAST LONDON NHS FOUNDATION TRUST and funded by NIHR Central Commissioning Facility (CCF) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 41662
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
